Han Shuo, Chen Xinru, Huang Leaf
Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Department of Toxicology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510000, China.
Acta Pharm Sin B. 2023 Apr;13(4):1371-1382. doi: 10.1016/j.apsb.2022.12.005. Epub 2022 Dec 13.
Long non-coding RNAs (lncRNAs) is a type of RNA over 200 nt long without any protein coding ability, which has been investigated relating to crucial biological function in cells. There are many key lncRNAs in tumor/normal cells that serve as a biological marker or a new target for tumor treatment. However, compared to some small non-coding RNA, lncRNA-based drugs are limited in clinical application. Different from other non-coding RNA, like microRNAs, most lncRNAs have a high molecular weight and conserved secondary structure, making the delivery of lncRNAs more complex than the small non-coding RNAs. Considering that lncRNAs constitute the most abundant part of the mammalian genome, it is critical to further explore lncRNA delivery and the subsequent functional studies for potential clinical application. In this review, we will discuss the function and mechanism of lncRNAs in diseases, especially cancer, and different approaches for lncRNA transfection using multiple biomaterials.
Acta Pharm Sin B. 2023-4
Int J Biochem Cell Biol. 2013-6-4
Acta Pharm Sin B. 2021-2
Cancer Lett. 2013-10-30
Mol Biol Rep. 2017-4
Pathol Res Pract. 2018-10
Hum Reprod Update. 2016-9-21
Naunyn Schmiedebergs Arch Pharmacol. 2025-9-1
Discov Oncol. 2025-8-28
Noncoding RNA. 2025-7-3
Naunyn Schmiedebergs Arch Pharmacol. 2025-7-11
Cardiovasc Diagn Ther. 2025-4-30
J Control Release. 2022-2
Cell Death Dis. 2021-11-10
Biomedicines. 2021-5-10
J Environ Public Health. 2021